Cantitate/Preț
Produs

Artificial Intelligence for Multi-omics Analysis Part B: Progress in Molecular Biology and Translational Science, cartea 222

David B. Teplow, Vijai Singh Sudipto Saha
en Limba Engleză Hardback – apr 2026
Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

  • Provides the latest information on Artificial Intelligence for multi-omics Analysis research
  • Offers outstanding and original reviews on a range of Artificial Intelligence for multi-omics Analysis research topics
  • Serves as an indispensable reference for researchers and students alike
Citește tot Restrânge

Din seria Progress in Molecular Biology and Translational Science

Preț: 71603 lei

Preț vechi: 78685 lei
-9% Precomandă

Puncte Express: 1074

Preț estimativ în valută:
12668 14781$ 11076£

Carte nepublicată încă

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443413490
ISBN-10: 0443413495
Pagini: 300
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
Seria Progress in Molecular Biology and Translational Science


Cuprins

1. Artificial Intelligence in multi-omics analysis of small molecule drug discovery
2. AI in multi-omics analysis in antimicrobial resistance
3. Artificial Intelligence and multi-Omics Approach in Vaccine Development
4. Artificial Intelligence in multi-omics Analysis of heart diseases
5. Artificial Intelligence in multi-omics Analysis of Kidney Diseases
6. Artificial Intelligence in multi-omics Analysis of Gastrointestinal Diseases
7. AI in multi-omics analysis in Stem cell research
8. AI in multi-omics analysis in cancer
9. AI in multi-omics analysis in obstructive lung diseases
10. AI in multi-omics analysis in neurodiseases
11. AI in multi-omics analysis in autoimmune diseases
12. AI in multi-omics analysis of liver diseases
13. AI in multi-omics analysis of COVID-19 patient data
14. AI in multi-omics analysis of Type 2 diabetes